BiotechTube
Home/AboleIIs Pharma/Dr. Carole Guillonneau
DC

Dr. Carole Guillonneau

Co-founder and Head of Research

AboleIIs Pharma

Therapeutic Areas

Autoimmune DiseasesTransplantationInflammatory Diseases

AboleIIs Pharma Pipeline

DrugIndicationPhase
ABO21009Rheumatoid Arthritis (RA)Phase 1

Leadership Team at AboleIIs Pharma

DI
Dr. Ignacio Anegon
Co-founder, Senior Consultant, and Member of the Scientific Advisory Board
DF
Dr. François-Xavier Hubert
Co-founder, Past President, and Board Member
AM
Ann Meulemans
Chief Executive Officer (CEO)
View full AboleIIs Pharma profile